Diabetes, Vol 44, Issue 11 1259-1265, Copyright © 1995 by American Diabetes Association
Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM
SC Elbein, KC Chiu, MD Hoffman, RA Mayorga, KL Bragg and MF Leppert
Division of Endocrinology, Metabolism and Diabetes, Veterans Affairs Medical Center, Salt Lake City, Utah 84148, USA.
As part of an ongoing search for diabetes susceptibility loci, we tested
linkage with non-insulin-dependent diabetes mellitus (NIDDM) for 19
candidate loci or regions chosen for their potential to affect directly or
indirectly the action of insulin. Loci were associated with insulin
resistance, known effects on lipid metabolism, or effects on glucose
metabolism or insulin action. Loci included the insulin-responsive (GLUT4)
glucose transporter, hexokinase 2, glucagon, growth hormone, insulin
receptor substrate 1 (IRS1), phosphoenolpyruvate carboxykinase, hepatic and
muscle forms of pyruvate kinase, hepatic phosphofructokinase, the
apolipoprotein B and the apolipoprotein A2 cluster, lipoprotein lipase,
hepatic triglyceride lipase, the very-low-density-lipoprotein receptor, and
the Pima insulin resistance locus on chromosome 4. For several candidates,
no specific informative marker was available; consequently, we tested the
surrounding region with highly informative markers. These regions included
the diabetes-associated ras-like gene, rad, and the cholesterol
ester-transfer gene, both mapped to chromosome 16. Additionally, we tested
for linkage with markers at the tumor necrosis factor-alpha gene and the
Friedreich's ataxia region. All regions were tested for linkage with
microsatellite polymorphisms in > 450 individuals from a minimum of 16
Caucasian families under parametric (LINKAGE 5.1) and nonparametric
(affected pedigree member) models.(ABSTRACT TRUNCATED AT 250 WORDS)